Robert Benza
Ophthalmology · Cincinnati, OHNPI 1912966144
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 55 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 22.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,014 and has fallen 86.8% since, to $134 in 2022. That places this record below the midpoint for ophthalmology clinicians in OH, where the typical reported total is $1,115.
Across 55 payments — averaging $25.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aerie Pharmaceuticals, Inc.$317
- AbbVie$317
- Bausch & Lomb, A Division Of Bausch Health US, LLC$239
- Sun Pharmaceutical Industries Inc.$211
- Alcon$97
- Novartis$55
- plus $191 from 9 others
Across 23 payments — averaging $9677.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$99K
- Ocular Therapeutix, Inc.$63K
- Kala Pharmaceuticals, Inc.$30K
- Sun Pharmaceutical Industries Inc.$30K
- Osmotica Pharmaceutical Corp.$2K
What the payments were for
- Food & beverage$1,427100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aerie Pharmaceuticals, Inc. | 12 | $317 |
| AbbVie(2 entities) | 8 | $317 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 9 | $239 |
| Sun Pharmaceutical Industries Inc. | 4 | $211 |
| Alcon | 6 | $97 |
| Novartis | 3 | $55 |
| Bausch & Lomb Americas Inc. | 2 | $37 |
| Shire North American Group Inc | 2 | $34 |
| Kala Pharmaceuticals, Inc. | 2 | $28 |
| Biotissue Holdings Inc. | 2 | $23 |
| Amgen | 1 | $15 |
| Eyevance Pharmaceuticals LLC | 1 | $14 |
| Spark Therapeutics, Inc. | 1 | $14 |
| Ocular Therapeutix, Inc. | 1 | $13 |
| Johnson & Johnson Vision Care, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,427 in reported general payments places this provider in the 50th percentile of 640 ophthalmology providers in Ohio.
Other ophthalmology in Cincinnati
- Robert OsherCincinnati$720K
- Christopher RiemannCincinnati$463K
- Anup KhatanaCincinnati$347K
- Michael SnyderCincinnati$216K
- Daniel MillerCincinnati$75K
- Robert SiskCincinnati$46K
- Michael NordlundCincinnati$40K
- Adam KaufmanCincinnati$19K
- Haroon ChaudhryCincinnati$18K
- Karen KlugoCincinnati$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.